Diagnostic Medical Systems S.A. (LON:0RIA)
1.415
-0.005 (-0.35%)
At close: Oct 17, 2025
LON:0RIA Revenue
Diagnostic Medical Systems had revenue of 24.82M EUR in the half year ending June 30, 2025, with 13.89% growth. This brings the company's revenue in the last twelve months to 49.47M, up 9.16% year-over-year. In the year 2024, Diagnostic Medical Systems had annual revenue of 48.86M with 10.74% growth.
Revenue (ttm)
49.47M EUR
Revenue Growth
+9.16%
P/S Ratio
0.72
Revenue / Employee
383.52K EUR
Employees
129
Market Cap
30.34M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 48.86M | 4.74M | 10.74% |
| Dec 31, 2023 | 44.12M | 7.06M | 19.05% |
| Dec 31, 2022 | 37.06M | -972.00K | -2.56% |
| Dec 31, 2021 | 38.03M | 3.00M | 8.57% |
| Dec 31, 2020 | 35.03M | 865.00K | 2.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.19B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| HSBC Holdings | 42.39B |
| AstraZeneca | 41.24B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| British American Tobacco p.l.c. | 25.60B |